593 related articles for article (PubMed ID: 26958008)
1. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
[TBL] [Abstract][Full Text] [Related]
2. Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
Agyeman YN; Newton S; Annor RB; Owusu-Dabo E
PLoS One; 2021; 16(4):e0250350. PubMed ID: 33878140
[TBL] [Abstract][Full Text] [Related]
3. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
Owusu-Boateng I; Anto F
Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
[TBL] [Abstract][Full Text] [Related]
4. Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015.
Oppong FB; Gyaase S; Zandoh C; Nettey OEA; Amenga-Etego S; Anane EA; Adda R; Dosoo DK; Owusu-Agyei S; Asante KP
BMJ Open; 2019 Jun; 9(6):e027946. PubMed ID: 31230017
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana.
Vandy AO; Peprah NY; Jerela JY; Titiati P; Manu A; Akamah J; Maya ET; Torpey K
BMC Pregnancy Childbirth; 2019 Nov; 19(1):424. PubMed ID: 31747927
[TBL] [Abstract][Full Text] [Related]
6. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
[TBL] [Abstract][Full Text] [Related]
8. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
[TBL] [Abstract][Full Text] [Related]
9. Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana.
Amoako BK; Anto F
BMC Pregnancy Childbirth; 2021 Feb; 21(1):105. PubMed ID: 33530957
[TBL] [Abstract][Full Text] [Related]
10. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
Azizi SC
BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
[TBL] [Abstract][Full Text] [Related]
11. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
[TBL] [Abstract][Full Text] [Related]
12. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR
BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878
[TBL] [Abstract][Full Text] [Related]
13. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
[TBL] [Abstract][Full Text] [Related]
14. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
[TBL] [Abstract][Full Text] [Related]
15. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP
Malar J; 2007 Nov; 6():144. PubMed ID: 17996048
[TBL] [Abstract][Full Text] [Related]
16. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
[TBL] [Abstract][Full Text] [Related]
17. Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study.
Owusu R; Asante KP; Mahama E; Awini E; Anyorigiya T; Dosoo D; Amu A; Jakpa G; Ofei E; Segbaya S; Oduro AR; Gyapong M; Hodgson A; Bart-Plange C; Owusu-Agyei S
PLoS One; 2015; 10(9):e0136828. PubMed ID: 26327623
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
Tutu EO; Lawson B; Browne E
Malar J; 2011 Dec; 10():385. PubMed ID: 22206597
[TBL] [Abstract][Full Text] [Related]
19. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial.
Tagbor H; Bruce J; Agbo M; Greenwood B; Chandramohan D
PLoS One; 2010 Dec; 5(12):e14425. PubMed ID: 21203389
[TBL] [Abstract][Full Text] [Related]
20. A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
Mbonye AK; Yanow S; Birungi J; Magnussen P
BMC Pregnancy Childbirth; 2013 Sep; 13():178. PubMed ID: 24053142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]